Clinical Trial Update: Adacolumn in Refractory UC Patients Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update showing the completion of a study evaluating Adacolumn in patients with active moderate ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Adacolumn (granulocyte and monocyte adsorptive apheresis column)

Snippet

Sponsor: Otsuka Pharmaceutical Europe Ltd | Conditions: Ulcerative Colitis, Active Moderate | Phase 4 | Status: COMPLETED